SRPT - Sarepta Therapeutics, Inc.
16.09
0.220 1.367%
Share volume: 2,068,645
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$15.87
0.22
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-01-2024 | 08-07-2024 | 11-06-2024 | 02-28-2025 | 05-06-2025 | 08-06-2025 | 11-06-2025 | |
| Assets | ||||||||
| Total Assets | 3.224 B | 3.424 B | 3.600 B | 3.963 B | 3.465 B | 3.680 B | 3.493 B | |
| Current Assets | 2.465 B | 2.684 B | 2.685 B | 3.073 B | 2.433 B | 2.657 B | 2.722 B | |
| Inventories | 373.530 M | 485.795 M | 565.924 M | 749.960 M | 941.432 M | 994.036 M | 1.077 B | |
| Other Current Assets | 288.485 M | 74.743 M | 165.477 M | 90.461 M | 105.478 M | 127.594 M | 192.349 M | |
| Short Term Investments | 288.485 M | 1.077 B | 1.001 B | 251.782 M | 281.895 M | 289.541 M | 237.916 M | |
| Total Receivables | 412.107 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.391 B | 383.622 M | 197.855 M | 1.103 B | 240.867 M | 510.598 M | 613.077 M | |
| Total Non-current Assets | 759.520 M | 0.000 | 181.770 M | 133.163 M | 263.495 M | 230.126 M | 1.040 M | |
| Property Plant Equipment | 249.302 M | 276.200 M | 305.788 M | 340.336 M | 360.587 M | 371.857 M | 358.936 M | |
| Other Assets | 331.983 M | 464.421 M | 608.777 M | 549.374 M | 672.267 M | 650.972 M | 412.192 M | |
| Intangible Assets | 28.930 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 3.224 B | 3.424 B | 3.600 B | 3.963 B | 3.465 B | 3.680 B | 3.493 B | |
| Total liabilities | 2.263 B | 2.347 B | 2.379 B | 2.435 B | 2.323 B | 2.322 B | 2.173 B | |
| Total current liabilities | 608.709 M | 688.490 M | 699.489 M | 731.684 M | 605.588 M | 919.948 M | 921.425 M | |
| Accounts Payable | 91.536 M | 107.417 M | 118.774 M | 214.442 M | 156.105 M | 136.702 M | 94.015 M | |
| Other liabilities | 380.722 M | 198.888 M | 218.409 M | 241.623 M | 253.787 M | 263.023 M | 216.746 M | |
| Current long term debt | 105.586 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.134 B | 1.135 B | 1.136 B | 1.137 B | 1.138 B | 1.139 B | 1.035 B | |
| Other liabilities | 380.722 M | 198.888 M | 218.409 M | 241.623 M | 253.787 M | 263.023 M | 216.746 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 961.192 M | 1.077 B | 1.221 B | 1.528 B | 1.143 B | 1.357 B | 1.320 B | |
| Common stock | 93.991 M | 5.482 B | 5.589 B | 5.739 B | 5.801 B | 5.844 B | 5.987 B | |
| Retained earnings | -4.410 B | -4.404 B | -4.370 B | -4.211 B | -4.658 B | -4.462 B | -4.642 B |